Literature DB >> 22923341

Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients.

Alan Cheng1, Sean R Landman, Robert W Stadler.   

Abstract

BACKGROUND: The efficacy of cardiac resynchronization therapy (CRT) is associated with the amount of CRT pacing delivered. The specific causes of CRT pacing loss and their relative frequencies remain poorly defined. METHODS AND
RESULTS: CRT patients who transmitted device data from 2006 to 2011 were screened for inclusion. Device diagnostics were analyzed using an automated algorithm to categorize CRT loss into 10 different causes. The algorithm was validated against manual adjudications using a portion of the entire cohort. There were 80 768 patients analyzed with a median time of 594 (interquartile range, 294-1003) days from implant to time of analysis. In this cohort, 40.7% of patients had <98% pacing, and 11.5% of patients had <90% pacing. For patients with <98% pacing, device diagnostics explained 55.8% of pacing loss: 30.6% atrial tachycardia/atrial fibrillation; 16.6% premature ventricular contractions; and 8.6% captured as episodes with at least 10 consecutive beats of CRT loss (ventricular sensing episodes). Inappropriately programmed sensed and paced atrioventricular (AV) intervals (SAV/PAV) accounted for 34.5% of all ventricular sensing episodes. As the severity of CRT loss increased, the contribution of atrial tachycardia/atrial fibrillation and SAV/PAV to the loss increased. Atrial tachycardia/atrial fibrillation accounted for >50% and premature ventricular contractions accounted for <10% of CRT loss in those with <90% CRT pacing.
CONCLUSIONS: CRT pacing <98% was observed in 40.7% of patients. Among those with suboptimal pacing, atrial tachycardia/atrial fibrillation was the most common reason for CRT pacing loss. Inappropriately programmed SAV/PAV intervals was the most common reason for episodes of sustained loss of CRT pacing. This information can help in defining more effective treatments to improve CRT delivery.

Entities:  

Mesh:

Year:  2012        PMID: 22923341     DOI: 10.1161/CIRCEP.112.973776

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  25 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 2.  Recent advances in the optimization of cardiac resynchronization therapy.

Authors:  Satish Chandraprakasam; Gina G Mentzer
Journal:  Curr Heart Fail Rep       Date:  2015-02

3.  Is There a Future for Remote Cardiac Implantable Electronic Device Management?

Authors:  Haran Burri
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-08

4.  Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy.

Authors:  Anne-Christine Ruwald; Mehmet K Aktas; Martin H Ruwald; Valentina Kutyifa; Scott McNitt; Christian Jons; Suneet Mittal; Jonathan S Steinberg; James P Daubert; Arthur J Moss; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-20       Impact factor: 1.468

Review 5.  Cardiac Resynchronization Therapy-Emerging Therapeutic Approaches.

Authors:  Neal A Chatterjee; E Kevin Heist
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-06

6.  Device therapy in heart failure with reduced ejection fraction-cardiac resynchronization therapy and more.

Authors:  D Duncker; C Veltmann
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

Review 7.  Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.

Authors:  Shantanu Sarkar; Paul D Ziegler
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 8.  Management of Patients with Atrial Fibrillation: Focus on Treatment Options.

Authors:  Pawel Matusik; Jacek Lelakowski; Barbara Malecka; Jacek Bednarek; Remigiusz Noworolski
Journal:  J Atr Fibrillation       Date:  2016-10-31

Review 9.  [Management of premature ventricular ectopy in cardiac resynchronization therapy : Treatment strategies for an optimized cardiac resynchronization].

Authors:  Benjamin Rath; Julia Köbe; Florian Reinke; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-01-29

Review 10.  Electromechanical dyssynchrony and resynchronization of the failing heart.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.